Learn to recognize the upper and lowercase letter D, how to write the letter Dd and the sound that letter D makes. This series incorporates the modalities of visual, auditory and kinesthetic...

2024年12月16日 · 糖尿病肾脏疾病（DKD）是糖尿病最常见的并发症之一，已成为我国慢性肾脏病的首要病因。 由于基层医院医疗资源欠缺、患者健康意识薄弱，呈现 DKD检出率及治疗率低、血糖控制达标率低、进展速度快 的特点，规范诊治与随访管理已迫在眉睫。 糖尿病患者出现下列情况之一： 随机尿白蛋白/尿肌酐比值（UACR）≥30 mg/g或尿白蛋白排泄率（UAER）≥30 mg/24h，且在3～6个月内重复检查3次UACR或UAER中有2次达到或超过临界值；排除感染等 …

2019年3月3日 · Diabetic kidney disease (DKD) is one of the common long-term, microvascular complications of diabetes. DKD remains the most common cause of end-stage renal disease (ESRD), accounting for about half of all ESRD cases. [72]

2023年8月25日 · In this article, we review the evolution of the pillar concept of therapy as it applies to DKD and discuss how it should be used based on the outcome evidence. We also discuss the exciting possibility that GLP-1 RAs may be an additional pillar in the quest to further slow kidney disease progression in diabetes.

This video is Part 1 of the Alphabet ABC Phonics Series, covering letters A, B, C, D, E, F, and G. This series goes through each of the letters, starting with A and ending with Z. Each letter...

Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide and the single strongest predictor of mortality in patients with diabetes. DKD is a prototypical disease of gene and environmental interactions.

2019年6月15日 · Screening for early DKD is best done with annual spot urine albumin/creatinine ratio testing, and diagnosis is confirmed by repeated elevation in urinary albumin excretion. Treatment includes management of hyperglycemia, hypertension, hyperlipidemia, and …

Diabetic kidney disease (DKD) is a chronic complication of diabetes mellitus which may eventually lead to end-stage kidney disease (ESKD).

目前（2020年），国内的主流日语能力标准依然还是JLPT，大家提起日语能力级别，立马想到的就是N5~N1。殊不知，在日本国内的日语教育，以及欧美国家的日语教育，却正在如火如荼的实施着另一个标准 - JF Standard。 它的等级设定，和 欧标的CEFR保持一致，从A1到C2。

2022年3月21日 · FIDELIO‐DKD and FIGARO‐DKD enrolled patients with different levels of kidney dysfunction. With established benefits, finerenone could improve outcomes in many patients with type 2 diabetes and CKD. However, this population has faced challenges in uptake of guideline‐directed therapy.